In this episode, AGG Employment partner and co-chair, Ashley Kelly, speaks with leaders of the firm's new Civil Rights & False Claims Act Risk & Response Team, Gabe Scannapieco and Sara Lord, about the DOJ’s recent move to...more
7/9/2025
/ Compliance ,
Department of Justice (DOJ) ,
Diversity and Inclusion Standards (D&I) ,
Employer Responsibilities ,
Enforcement Actions ,
False Claims Act (FCA) ,
Federal Contractors ,
Regulatory Requirements ,
Reporting Requirements ,
Risk Management ,
Whistleblowers
The U.S. Department of Justice (“DOJ”) and the U.S. Department of Health and Human Services (“HHS”) have announced the formation of a newly strengthened False Claims Act (“FCA”) Working Group, signaling a more coordinated and...more
The Department of Justice (“DOJ”) continues to expand the Civil Division’s role in enforcing and implementing policies that have been announced through the President’s Executive Orders....more
Delivering on his campaign pledges since assuming office, President Trump has dramatically increased immigration enforcement. There are numerous, well-reported instances of undocumented immigrants being arrested and sent to...more
On June 3, 2025, Judge Matthew F. Kennelly of the U.S. District Court for the Northern District of Illinois issued a sweeping ruling in In re MultiPlan Health Insurance Provider Litigation, largely denying motions to dismiss...more
6/19/2025
/ Antitrust Litigation ,
Antitrust Violations ,
Competition ,
Health Insurance ,
Hospitals ,
Insurance Industry ,
Insurance Litigation ,
Multidistrict Litigation ,
Out of Network Provider ,
Physicians ,
Price-Fixing
On June 9, 2025, the U.S. Department of Justice released a memorandum titled “Guidelines for Investigations and Enforcement of the Foreign Corrupt Practices Act (FCPA),” formalizing an anticipated realignment of federal...more
AGG’s Government Investigations Team Insights provides periodic updates covering legal and regulatory topics. Our team, which includes former federal prosecutors, SEC enforcement attorneys, and federal agency attorneys, has...more
In his first major public remarks as commissioner of the U.S. Food and Drug Administration, Dr. Marty Makary laid out a comprehensive, reform-oriented vision for the agency during a fireside chat at the 2025 Food & Drug Law...more
On February 5, 2025, Attorney General Bondi issued a Memorandum, “Ending Illegal DEI and DEIA Discrimination and Preferences,” which was designed to implement President Trump’s Executive Order 14173, “Ending Illegal...more
On May 12, 2025, the U.S. Department of Justice’s Criminal Division unveiled an overhaul of its white-collar enforcement policies in a memo issued by Matthew Galeotti, head of the Criminal Division. The memo, titled “Focus,...more
5/16/2025
/ Corporate Crimes ,
Corporate Governance ,
Corporate Misconduct ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Enforcement Priorities ,
Fraud ,
Government Investigations ,
Healthcare Fraud ,
Investigations ,
Voluntary Disclosure ,
Whistleblowers ,
White Collar Crimes
The Department of Justice’s decision to shutter the Consumer Protection Branch (“CPB”) by September 30, 2025, is sending shockwaves across multiple industries. Known for its unique dual mandate to pursue both civil and...more
5/13/2025
/ Consumer Protection Laws ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Fraud ,
FTC Act ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Prescription Drugs
In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by Gabe Scannapieco, AGG Litigation & Dispute Resolution partner, to discuss enforcement trends affecting foreign...more
On February 18, 2025, in a closely watched decision, the United States Court of Appeals for the First Circuit in United States v. Regeneron Pharmaceuticals Inc., No. 23-2086, 2025 U.S. App. LEXIS 3667 (1st Cir. Feb. 18, 2025)...more
AGG’s Government Investigations Team Insights provides periodic updates covering legal and regulatory topics. Our team, which includes former federal prosecutors and federal agency attorneys, has successfully represented...more
As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, less attention has been given to the new administration’s regulatory impact abroad....more
Q: If you had 30 seconds to describe your practice, what would you say? A: I am a partner in AGG’s Litigation & Dispute Resolution practice, focusing on government investigations, white-collar defense, and commercial...more
2/11/2025
/ Anti-Kickback Statute ,
Career Development ,
Client Services ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Government Investigations ,
Healthcare Fraud ,
Professional Development ,
Professional Networking ,
Relationship Development